Formulation Development

Pharmaceutical formulation development is the critical step which links the discovery of a novel drug to commercialization. During this step, formulation scientists will determine the best drug delivery vehicle and dosage form needed to deliver a therapeutic effect based on bioavailability or other factors. Below you can explore articles, industry trends, and curated products which can help increase formulation development efficiency.

An Interview with Sabrina Graf- COO, Tenthpin
I think the main developments have been the automation of complex processes, the improvement of data accuracy, and ensuring adherence to regulatory standards (GxP). This is what we hear from the top and leading global pharma companies as well when working with them. Vast datasets can be monitored in real-time, promptly identifying deviations or ... read more
An Interview with Scott Bone – Head of Formulation and Process Science, Bend Bioscience
The industry must adopt a science-driven, data-informed development strategy. A foundational understanding of the active pharmaceutical ingredient’s (API) physicochemical properties, the matrix characteristics, and the drug’s pharmacokinetic (PK) and pharmacodynamic (PD) profiles is essential. Leveraging these insights early in development ... read more
Pharmaceutical P.I.N. Points: Patent Innovation News
The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in March 2025. read more

Oral Drug Absorption - An Understanding of Lymphatic versus Portal Transport and Food Effect
Oral drugs face major challenges like poor solubility, low permeability, and enzymatic degradation, which limit their effectiveness. This article explores cutting-edge strategies to enhance drug absorption through the lymphatic system, including lipid nanoparticles, lipid prodrugs, and food-based approaches. Learn how these ... read more
Nanoparticle Technologies: Enablers for Ocular Drug Delivery
As we continue to discover new and innovative small molecules and therapeutic compounds, over 80% of those candidates in drug pipeline are challenging to development due to their poor solubility and bioavailability. There are several ocular barriers such as tear film, corneal, conjunctival and blood barriers that cause the ... read more
Clean Labeling in Pharma: Enhancing Transparency and Trust
This article explores the significance of clean labeling in the pharma industry and how it is being utilized to meet consumer expectations. read more
eBook: Formulation Technologies and Strategies for Successful New Product Development
Whether it's an innovative new therapeutic modality or a supplier suddenly falling out of regulatory compliance, disruptions come in known challenges and unexpected obstacles. Control is what allows you to decide the shape that disruption will take. read more
Infographic: Seven Softgel Myths
Softgels are a popular dose format among consumers thanks to their high swallowability and quick onset of action. Yet pharmaceutical developers may not even consider softgels. Why the disconnect? Here are seven popular misconceptions about softgels and the facts that disprove them. read more